2-(3-Methoxypropoxy)-4-((R)-2-(bromomethyl)-3-methylbutyl)-1-methoxybenzene, 95.0%, 1g

3-(tert-Butyl)-4-(2,6-diisopropoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

PIMAVANSERIN, 95%, 5g

(2E)-3-(4-tert-butylphenyl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 3,4-difluorobenzoate, 97.0%, 500g

Spherical ground joints, 40, 120 mm, 1 Piece

(S)-1-(4-(tert-Butyl)phenyl)ethan-1-amine, 97%, 1g

5-Ethynylpyridin-3-ol, 98%, 250mg

1-Chloroisoquinoline-5-sulfonyl chloride, 97%, 250mg

Methyl 2-hydroxy-5-nitronicotinate, 97.0%, 1g

2H-Chromene-3-carboxylic acid, 95.0%, 250mg

Bis(4-nitrophenyl) Phosphate [for Phosphodiesterase Substrate]>98.0%(T)1g

tert-Butyl 5-bromopicolinate, 95.0%, 10g